EGFR and lung carcinoma: In addition to oncogenic Ras mutations, 15–30% of samples of NSCLC, which make up 85% of total lung cancers, were also found positive for overexpression of EGFR [70], which signals via Ras, and has been implicated in their increased ability to invade and metastasize [70].